In this interview, Catherine Godson, PhD discusses the protective role of lipoxins against inflammation in diabetes associated atherosclerosis. She offers insights into the future direction of research focused on inflammation resolution. Dr. Godson emphasizes the necessity for treatments targeting chronic complications of diabetes, which promotes resolution on top of standard care therapies. She also elaborates on her research involving lipoxins in the context of chronic complications of disease and inflammation.
Catherine Godson, PhD, is a Professor of Molecular Medicine and Director of UCD Diabetes Complications Research Centre at University College Dublin.
From the 17th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases, October 2022 in New Orleans, Louisiana
